(1.3% vs. 11.3%; p¼0.025). The 2-year cardiac survival was higher in patients with a complete coronary revascularization as compared to patients with incomplete revascularization (96% AE 3% vs. 78% AE 7%; p¼0.002); completeness of revascularization was inversely related to the risk of death (HR 0.10; p¼0.029). Conclusions: In patients with multiple CTOs a successful PCI of all CTOs was associated with increased cardiac survival, and completeness of revascularization was a strong predictor of survival.
UT Southwestern
Medical Center and VA North Texas Health Care System, Dallas, TX, Dallas, TX Background: There is a paucity of data on the long-term clinical outcomes of successful percutaneous coronary intervention (PCI) of coronary chronic total occlusions (CTOs) using the retrograde approach. Methods: We performed a retrospective analysis of the long-term clinical outcomes of 193 consecutive patients who underwent successful CTO PCI at our institution between December 2008 and December 2011. Results: Mean age was 63.6AE8.3 years, 98% of patients were men, 42% had diabetes, 20% had prior coronary artery bypass graft (CABG) surgery and 34% had prior PCI. The retrograde approach was used in 41 patients (21.2%). The CTO target vessel was more frequently the right coronary artery among patients who underwent retrograde CTO PCI (78.1% vs. 45.7%, p¼0.001) . The mean stent length was longer in the retrograde group (83AE32 vs. 64AE32 mm, p¼0.001). During a median follow-up of 2.0 years (interquartile range, 1.36 to 3.22 years), compared to antegrade CTO PCI group, patients who underwent retrograde CTO PCI had higher target lesion revascularization (TLR) (45.6% vs. 25.7%, p¼0.006) (Figure 1 ). There was no significant difference in the incidence of all-cause mortality, myocardial infarction, non-target vessel revascularization or CABG between the two groups. Conclusions: Retrograde CTO PCI was associated with higher incidence of TLR, but similar incidence of death and myocardial infarction. These findings likely reflect the higher complexity of CTO lesions and long stent lengths needed in those treated with the retrograde approach. Background: Coronary chronic total occlusion (CTO) is frequently associated with multivessel disease. Large registries have shown a higher mortality in patients with unsuccessful CTO-PCI for left anterior descending artery (LAD) as compared to nonLAD-CTO. Furthermore, patients with incomplete coronary revascularization due to non attempted or failed CTO-PCI had a poor prognosis as compared to patients with a complete revascularization. No data exist about the prognostic impact of drug eluting stent (DES) supported successful PCI for LAD-CTO in patients with a complete coronary revascularization achieved by PCI. Methods: From the prospective Florence CTO-PCI registry, since 2004 to 2010, 644 patients underwent a successful PCI for CTO (>3 months) with a complete coronary revascularization within one month. The prognostic impact of LAD-CTO on cardiac mortality was assessed by Kaplan-Meier estimation and by forward stepwise Cox regression multivariate analysis. Results: A successful CTO-PCI with a complete coronary revascularization was achieved in 194 patients with LAD-CTO and in 450 patients with nonLAD-CTO. Baseline characteristics of patients with LAD-CTO vs. nonLAD-CTO were similar: mean age 68 AE 11 vs. 67 AE 11 yrs, male 83% vs. 86%, diabetes 22% vs. 23%, previous myocardial infarction 51% vs. 48%, acute coronary syndrome at admission 34% vs. 29%, 3-vessel coronary disease 43% vs. 48%, left ventricular ejection fraction (EF) 44% AE 13 vs. 45% AE 12, stent length >40 mm in LAD-CTO 51% vs. 57% in non-LAD-CTO. A multivessel PCI was performed in 70% of both groups. The clinical follow-up rate was 100% (median 1 yr). The cardiac survival rate was higher in the nonLAD-CTO group as compared to LAD-CTO group (96% AE 2% vs 89% AE 3%; p¼0.004). At multivariate analysis the independent predictors related to cardiac mortality were LAD-CTO (HR 2.9; p¼0.025), age (HR 1.1; p¼0.002) and EF <0.40 (HR 14; p<0.001). Conclusions: The successful treatment of nonLAD-CTO associated with a complete revascularization links with a very high survival rate. LAD-CTO is a predictor of cardiac mortality despite the completeness of coronary revascularization. Background: Whether successful PCI of a coronary CTO is associated with improved survival is the subject of debate. Using a large prospective database of patients treated for CTO, we sought to compare long-term outcome of patients on the basis of success/ failure of the index PCI procedure. Methods: Between 2004 and 2012, a total of 1,343 consecutive patients underwent PCI for CTO in our centre (14 operators). We compared major adverse cardiac events (MACE) including cardiac death, target vessel revascularisation (TVR), and myocardial infarction (MI) in patients with successful versus failed PCI at a median follow up of 4.1 years (IQR: 2.4-6.5 years). Procedural success was defined as achievement of residual stenosis <50% with TIMI-3 flow in the target vessel. Results: Successful treatment of CTO by PCI was achieved in 1000 (74%) patients. These patients were younger (63AE11 vs. 65AE11 respectively p¼0,02), had lower rates of hypertension (56.1% vs. 66.8% p<0,01), previous MI (19.5 % vs. 29.2% p<0,01) and were more frequently treated for left anterior descending artery CTO (33.2 vs. 23.0%, p<0.01) than those in whom PCI success was not achieved. However, left ventricular ejection fraction and diabetes mellitus were similar between groups. PCI success was associated with significantly lower MACE among patients with successful PCI (16.7 vs. 22.2%, p¼ 0.0235) driven mainly by lower rate of cardiac death at follow up (4.2 vs. 11%, p<0.0001). Independent predictors of lower cardiac death by multivariate analysis were: successful PCI (HR: 0,42, 95% CI: 0.27-0.67, p < 0.01), absence of previous MI (HR: 1.68, 95% CI: 1.03-2.74, p ¼0.04) and younger age (HR: 1.05, 95% CI: 1.03-1.08, p < 0.01). Conclusions: In this large cohort of patients treated by PCI for CTO, successful revascularization was associated with improved clinical outcome at long-term followup. This was driven by lower cardiac mortality rates among these patients.
TCT-365

TCT-366
TCT-368
Long Background: To assess the procedural success rate and the long-term clinical impact of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in elderly patients. Methods: A total of 1,343 consecutive patients with underwent PCI for 1,432 CTO lesions between Jan 2004 and Jan 2012 at our center. Outcomes including procedural success and major adverse cardiac events (MACE) and its components, cardiac death, myocardial infarction and target vessel revascularization between patients aged !75 and patients aged <75 years were compared. Results: A total of 253 patients (19%) were aged !75 years. Compared to patients <75 years, elderly patient were more commonly female (20% vs. 11.8%, p<0.0001) and presented most commonly with left anterior descending coronary artery CTO (41.5% vs. 28.5%, p¼0.001). Procedural success rates were similar in both groups (74.9% vs. 72.7%, p ¼ 0.48). Median follow-up was 4.1 years (IQR: 2.4-6.5 years). MACE rates after successful versus failed PCI were 20.9% versus 29.8% in the elderly (p ¼ 0.15) and 21.0 versus 24.1% in younger patients (p ¼ 0.12). In elderly patients, this trend in reduction in MACE after successful PCI was driven by a significant reduction in cardiac mortality (Figure) . There was also a significant reduction in allcause mortality (21.1% vs. 35.9%, p ¼ 0.02) and no significant differences in the rate of MI (2.8% vs. 1.6%, p ¼ 0.597).
Conclusions: PCI for CTO has similar success rate in the elderly (!75 years) and is associated with a significant reduction in cardiac mortality when success is achieved.
TCT-369
Long Background: Routine follow-up angiogram data after successful recanalization of chronic total coronary occlusions (CTO) with a long total stent length (SL) are lacking. In the present study, we evaluated clinical and angiographic outcomes after successful recanalization of CTO with implantation of a long total SL. Methods: Routine follow-up angiogram were performed at 6 months after successful recanalization of 113 CTO (antegrade approach in 81% and retrograde approach in 19%) with a long SL (! 20mm) in 108 consecutive patients. Results: Mean number of stents was 3.8 AE 1.8 and mean total SL was 76 AE 33 mm (range 20-174 mm). Drug-eluting stents (DES) were used in 106 lesions with sirolimus-eluting stents (SES) in 100. Instent total reocclusion occurred in 2 DES lesions (1 SES and 1 DES non-SES). Restenosis rate was 18% in DES vs 71% in bare metal stents group (p ¼ 0.004). In the 100 SES sub-group (total SL 79 AE 33mm, range 23-174 mm and mean number of stents 3.9 AE 1.8) restenosis rate was 18%; a younger age and a longer total SL were found to be independent predictors of restenosis (HR 0.939, 95% CI 0.885-0.996, p ¼ 0.035 and HR 1.017, 95% CI 1.00-1.03 p ¼ 0.045, respectively); restenosis type was diffuse in only 11% and 89% were successfully treated by repeat percutaneous coronary intervention. During a median follow-up of 2 years (interquartile range: 1 to 4.3 years), major cardiac events other than those angiographically driven at routine follow-up angiogram occurred in 3 patients (cardiac surgery at 7, 8 and 9 months, respectively). Conclusions: Angiographic restenosis rate remains acceptable in patients with complex CTO successfully treated by a long total length of DES and restenosis can be successfully treated by repeat percutaneous coronary intervention in the vast majorty of cases. 
